Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia - PubMed (original) (raw)
Clinical Trial
Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia
Roos E Pouw et al. Clin Gastroenterol Hepatol. 2010 Jan.
Abstract
Background & aims: Radiofrequency ablation (RFA) is safe and effective for eradicating intestinal metaplasia and neoplasia in patients with Barrett's esophagus. We sought to assess the safety and efficacy of RFA in conjunction with baseline endoscopic resection for high-grade intraepithelial neoplasia (HGIN) and early cancer.
Methods: This multicenter, prospective cohort study included 24 patients (mean age, 65 years; median Barrett's esophagus, 8 cm), with Barrett's esophagus of < or =12 cm containing HGIN or early cancer, from 3 European tertiary-care medical centers. Visible lesions were endoscopically resected, followed by serial RFA. Focal escape endoscopic resection was used if Barrett tissue persisted despite RFA. Complete response, defined as all biopsies negative for intestinal metaplasia and neoplasia, was assessed during endoscopy with 4-quadrant biopsies taken every 1 cm of the original Barrett's segment 2 months after the patient was last treated.
Results: Twenty-three patients underwent pre-RFA endoscopic resection for visible lesions; 16 patients had early cancer and 7 patients had HGIN. The worst residual histology results, pre-RFA (after any endoscopic resection) were: HGIN (10 patients), low-grade intraepithelial neoplasia (11 patients), and intestinal metaplasia (3 patients). Neoplasia and intestinal metaplasia were eradicated in 95% and 88% of patients, respectively; after escape endoscopic resection in 2 patients, rates improved to 100% and 96%, respectively. Complications after RFA included melena (n = 1) and dysphagia (n = 1). After additional follow-up (median, 22 months; interquartile range, 17.2-23.8 months) no neoplasia recurred.
Conclusions: This European multicenter study to show that early neoplasia in Barrett's esophagus can be effectively and safely treated with RFA, in combination with prior endoscopic resection of visible lesions.
Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
- Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
Pouw RE, Peters FP, Sempoux C, Piessevaux H, Deprez PH. Pouw RE, et al. Endoscopy. 2008 Nov;40(11):892-8. doi: 10.1055/s-2008-1077675. Epub 2008 Nov 13. Endoscopy. 2008. PMID: 19009481 - Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H, Terheggen G, Rutz EM, Vieth M, Schumacher B. Neuhaus H, et al. Endoscopy. 2012 Dec;44(12):1105-13. doi: 10.1055/s-0032-1310155. Epub 2012 Sep 11. Endoscopy. 2012. PMID: 22968641 Clinical Trial. - Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
van Vilsteren FG, Alvarez Herrero L, Pouw RE, Visser M, Ten Kate FJ, van Berge Henegouwen MI, Schoon EJ, Weusten BL, Bergman JJ. van Vilsteren FG, et al. Endoscopy. 2012 Dec;44(12):1096-104. doi: 10.1055/s-0032-1325731. Epub 2012 Oct 29. Endoscopy. 2012. PMID: 23108809 - Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.
van Vilsteren FG, Bergman JJ. van Vilsteren FG, et al. Gastrointest Endosc Clin N Am. 2010 Jan;20(1):55-74, vi. doi: 10.1016/j.giec.2009.07.007. Gastrointest Endosc Clin N Am. 2010. PMID: 19951794 Review. - Endoscopic therapy of Barrett's esophagus.
Pech O, Ell C. Pech O, et al. Curr Opin Gastroenterol. 2009 Sep;25(5):405-11. doi: 10.1097/MOG.0b013e32832d9b71. Curr Opin Gastroenterol. 2009. PMID: 19474724 Review.
Cited by
- Current status of advanced gastrointestinal endoscopy training fellowships in the United States.
Heller SJ, Tokar JL. Heller SJ, et al. Adv Med Educ Pract. 2011 Jan 11;2:25-34. doi: 10.2147/AMEP.S13310. Print 2011. Adv Med Educ Pract. 2011. PMID: 23745073 Free PMC article. - Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.
Krishnan K, Pandolfino JE, Kahrilas PJ, Keefer L, Boris L, Komanduri S. Krishnan K, et al. Gastroenterology. 2012 Sep;143(3):576-581. doi: 10.1053/j.gastro.2012.05.005. Epub 2012 May 15. Gastroenterology. 2012. PMID: 22609385 Free PMC article. - Endoscopic management of Barrett esophagus.
Repaka A, Chak A. Repaka A, et al. Nat Rev Gastroenterol Hepatol. 2011 Sep 6;8(10):582-91. doi: 10.1038/nrgastro.2011.151. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21894201 Review. - Radiofrequency ablation versus hybrid argon plasma coagulation in Barrett's esophagus: a prospective randomised trial.
Knabe M, Wetzka J, Welsch L, Richl J, Michael F, Blößer S, Heilani M, Kronsbein H, May A. Knabe M, et al. Surg Endosc. 2023 Oct;37(10):7803-7811. doi: 10.1007/s00464-023-10313-5. Epub 2023 Aug 21. Surg Endosc. 2023. PMID: 37605011 Free PMC article. Clinical Trial. - Durability and predictors of successful radiofrequency ablation for Barrett's esophagus.
Pasricha S, Bulsiewicz WJ, Hathorn KE, Komanduri S, Muthusamy VR, Rothstein RI, Wolfsen HC, Lightdale CJ, Overholt BF, Camara DS, Dellon ES, Lyday WD, Ertan A, Chmielewski GW, Shaheen NJ. Pasricha S, et al. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1840-7.e1. doi: 10.1016/j.cgh.2014.04.034. Epub 2014 May 9. Clin Gastroenterol Hepatol. 2014. PMID: 24815329 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical